Clinical Trial Results:
Double blind, double dummy, randomized, two way cross-over study to compare the effects of Seretide® Evohaler (supplied by Allen & Hanburys, UK) and a generic test HFA pMDI (manufactured by Cipla Ltd, India) on functional respiratory imaging parameters in asthmatic patients.
Summary
|
|
EudraCT number |
2012-005789-36 |
Trial protocol |
BE |
Global completion date |
19 Jul 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Dec 2021
|
First version publication date |
13 Dec 2021
|
Other versions |
|
Summary report(s) |
Study report 2012-005789-36 Published paper |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.